Addiction Expert Witnesses in Maryland

This expert has nearly 20 years of experience in the epidemiology and behavioral science field, specializing in foodborne outbreaks, worksite health, workplace behaviors, consumer retail behavior, and, most recently, the impact of COVID-19 on human behavior. She earned a BA in math and psychology from Bradley University, an MS in epidemiology and biostatistics from the University of South Florida, and a PhD in public and community health from the University of Maryland. Formerly, this expert served as an adjunct professor in public health at Montgomery College. She then went on to serve as a program analyst for behavioral and social research programs at the National Institute of Aging and National Cancer Institute, along with serving as a deputy director of strategic and innovative programs at the National Institutes of Health. This expert was also the founder and director of the National Heart, Lung, and Blood Institute at the National Institutes of Health, as well as principal epidemiologist and global vice president of research and corporate services at Sodexo. Currently, she is the CEO of an epidemiology and behavioral science consulting firm in Maryland.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.